The impact of extracorporal circulation on therapy-related mortality and long-term survival of patients with renal cell cancer and intracaval neoplastic extension

2002 ◽  
Vol 20 (4) ◽  
pp. 227-231 ◽  
Author(s):  
Markus A. Kuczyk ◽  
Torsten Münch ◽  
Stefan Machtens ◽  
Volker Grünewald ◽  
Udo Jonas
Keyword(s):  
Renal Cell Cancer ◽  
Renal Cell ◽  
Cell Cancer ◽  
Term Survival ◽  
Extracorporal Circulation ◽  
Long Term Survival ◽  
The Impact ◽  
Related Mortality

Impact of tumor size on the long-term survival of patients with early stage renal cell cancer

2005 ◽  
Vol 23 (1) ◽  
pp. 50-54 ◽  
Author(s):  
M. Kuczyk ◽  
G. Wegener ◽  
A. S. Merseburger ◽  
A. Anastasiadis ◽  
S. Machtens ◽  
...  
Keyword(s):  
Renal Cell Cancer ◽  
Tumor Size ◽  
Renal Cell ◽  
Early Stage ◽  
Cell Cancer ◽  
Term Survival ◽  
Long Term Survival

Prognostic factors and long-term survival in renal cell cancer patients

2009 ◽  
pp. 1-7
Author(s):  
Kaisa Sunela ◽  
Matti Kataja ◽  
Eero Lehtinen ◽  
Tapio Salminen ◽  
Paula Kujala ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Cancer Patients ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Cell Cancer ◽  
Term Survival ◽  
Long Term Survival

Prognostic factors and long-term survival in renal cell cancer patients

2009 ◽  
Vol 43 (6) ◽  
pp. 454-460 ◽  
Author(s):  
Kaisa L. Sunela ◽  
Matti J. Kataja ◽  
Eero T. Lehtinen ◽  
Tapio K. Salminen ◽  
Paula M. Kujala ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Cancer Patients ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Cell Cancer ◽  
Term Survival ◽  
Long Term Survival

Influence of Body Mass Index and Smoking on the Long-Term Survival of Patients With Renal Cell Cancer

2013 ◽  
Vol 11 (4) ◽  
pp. 458-464 ◽  
Author(s):  
Kaisa Leea Sunela ◽  
Matti Jorma Kataja ◽  
Pirkko-Liisa Irmeli Kellokumpu-Lehtinen
Keyword(s):  
Body Mass Index ◽  
Body Mass ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Cell Cancer ◽  
Term Survival ◽  
Long Term Survival

1103: Long-Term Survival Following Nephrectomy for Renal Cell Carcinoma: The 15 Year UCLA Experience

2006 ◽  
Vol 175 (4S) ◽  
pp. 355-355
Author(s):  
Manuel Eisenberg ◽  
John S. Lam ◽  
Rakhee H. Goel ◽  
Allan J. Pantuck ◽  
Robert A. Figlin ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Term Survival ◽  
Long Term Survival

scholarly journals Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation

2021 ◽  
Vol 11 (2) ◽  
pp. 90
Author(s):  
Chih-Yang Hsiao ◽  
Ming-Chih Ho ◽  
Cheng-Maw Ho ◽  
Yao-Ming Wu ◽  
Po-Huang Lee ◽  
...  
Keyword(s):  
Patient Survival ◽  
Trough Level ◽  
Medical Center ◽  
Term Survival ◽  
Blood Concentrations ◽  
Long Term Survival ◽  
Tacrolimus Level ◽  
Cox's Model ◽  
The Impact

Tacrolimus is the most widely used immunosuppressant in liver transplant (LT) patients. However, the ideal long-term target level for these patients is unknown. This retrospective study aimed to investigate the impact of tacrolimus blood concentration five years after LT on long-term patient survival outcomes in adult LT recipients. Patients who underwent LT between January 2004 and July 2014 at a tertiary medical center were included in this study (n = 189). The mean tacrolimus blood concentrations of each patient during the fifth year after LT were recorded and the overall survival rate was determined. A multivariate analysis of factors associated with long-term survival was conducted using a Cox’s model. The median follow-up period was 9.63 years, and 144 patients (76.2%) underwent live donor LT. Sixteen patients died within 5 years of LT. In the Cox’s model, patients with a mean tacrolimus blood trough level of 4.6–10.2 ng/mL had significantly better long-term survival than those with a mean tacrolimus blood trough level outside this range (estimated hazard ratio = 4.76; 95% confidence interval: 1.34–16.9, p = 0.016). Therefore, a tacrolimus level no lower than 4.6 ng/mL would be recommended in adult LT patients.

Sign in / Sign up

Export Citation Format

Share Document